The evidence leans constructive3 supporting, 0 against, 1 worth knowing
Supporting
trading 13% above its 200-day average
up 28% over twelve months
matches macd just turned positive, which has beaten the market by +0.56 points over 20 sessions across 14,089 past signals
Against
nothing the data supports either way
Worth knowing
the 50-day and 200-day averages disagree, which usually means a turn in progress rather than a trend to lean on
What would change this read: a close below 510, its 200-day average.
Assembled automatically from the figures on this page — the scans matched, their measured record, the filed financials, the derivatives positioning and the peer comparison. It is not a recommendation, no one has spoken to the company, and every claim above can be checked against a number further down this page.
What is working, what is not
from the filings and from the price, with the figure behind every line
Working2
Trading 13.0% above its 200-day average, which is the line most investors use to separate a bull phase from a bear one.
+13.0%
Up 28.4% over the past year.
+28.4%
Needs watching
Nothing on this side tonight — not in the filings and not in the price.
Every figure here is computed — from the company’s own filings, or from its own closing prices. The wording is generated directly from the figures.
How it has performed
price return over each window, beside the median NSE stock over the same days
What the scans say today
2 of 47 matched on 10 Sep
STARHEALTH matches 2 of the 47 scans today, across 1 different kinds of evidence.
Return on capital uses profit before tax over equity plus borrowings. The textbook version adds finance costs back; those are not tagged reliably in quarterly filings, so this understates the ratio for a heavily borrowed company rather than flattering it. Balance sheets are filed half-yearly, so these can be up to six months behind the profit figures above.
Management filings were typically +0.06pt vs the market over the next 5 sessions (n=2,634) · AGM / EGM filings were typically +0.17pt vs the market over the next 5 sessions (n=8,423) · Analyst call filings were typically +0.11pt vs the market over the next 5 sessions (n=4,339)
Where the price stands
the same figures every scan on this site is computed from
Trend
Distance from the averages traders watch. Above all of them is a bull phase; below the 200-day is the line most investors use to say otherwise.
Versus 50-day average-1.1%
Versus 200-day average+13.0%
Below 52-week high-5.6%
Above 52-week low+35.5%
Momentum
How hard it has been pushed lately. Above 70 on RSI is stretched, below 30 is washed out — neither is a signal on its own.
RSI (14)48.4
Higher closes in last 53 of 5
Six-month return+24.81%
Risk and liquidity
What a position costs to hold and to exit. Position sizing starts with the daily swing, not with conviction.
largest twelve by market capitalisation. Market cap and P/E need filed financials, so blanks are companies whose filings have not been read yet
Recent sessions
what this stock has matched since the engine went live
This is the live record, not the backtest — the scans this stock actually appeared in on each stored session. A name that keeps reappearing is in a persistent condition; a one-day appearance usually is not.